Show pageBacklinksCite current pageExport to PDFFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Immunotherapy ====== {{rss>https://pubmed.ncbi.nlm.nih.gov/rss/search/1BWfEy0KKtyekmOtRwjEFeEF7_nolVqVyhNbdF38CVHORMK5Q3/?limit=15&utm_campaign=pubmed-2&fc=20231211030856}} ---- ---- Immunotherapy is a type of [[medical treatment]] that harnesses the body's own [[immune system]] to combat diseases, particularly [[cancer]] and certain [[autoimmune]] disorders. The [[immune system]] is a complex network of [[cell]]s, [[tissue]]s, and molecules that work together to defend the body against harmful invaders like [[bacteria]], [[virus]]es, and abnormal cells. ===== Types ===== [[Combination immunotherapy]]. [[CAR-T cell therapy]] [[Monoclonal Antibody]] [[Immune Checkpoint Inhibitor]] and combinations ===== Cancer Immunotherapy ===== see [[Cancer Immunotherapy]]. [[Glioblastoma Immunotherapy]]. ===== Stroke ===== The immune reaction during ischemia opens new doors for advanced targeted therapeutics. Nowadays stem cell therapy has shown better results in stroke-prone individuals. Few monoclonal antibodies like [[natalizumab]] have shown a great impact on pre-clinical and clinical stroke trial studies ((Chavda V, Madhwani K, Chaurasia B. [[Stroke]] and [[Immunotherapy]]: Potential Mechanisms and its implications as immune-therapeutics. Eur J Neurosci. 2021 Apr 7. doi: 10.1111/ejn.15224. Epub ahead of print. PMID: 33829590.)). immunotherapy.txt Last modified: 2025/04/29 20:27by 127.0.0.1